Uterine fibroids — benign (non-cancerous) growths of smooth muscle tissue within or on the uterus — are the most common benign tumors in women, affecting up to 70–80% of women by age 50. While many fibroids cause no symptoms, those that do can produce heavy menstrual bleeding (often severe enough to cause anemia), pelvic pressure and pain, urinary frequency, and reproductive effects including difficulty conceiving and pregnancy complications. Women’s health and gynecology clinics provide the evaluation and comprehensive management that addresses fibroid-related symptoms effectively. This guide explains clinical fibroid care.
Types by Location
Submucosal fibroids (within the uterine cavity) cause the most significant bleeding and have the greatest impact on fertility. Intramural fibroids (within the uterine wall) are the most common type, causing bulk symptoms and bleeding when large. Subserosal fibroids (on the outer uterine surface) primarily cause pressure and bulk symptoms. Location guides treatment selection more than size alone.
Non-Surgical Management
Hormonal medications that reduce estrogen levels (GnRH agonists, GnRH antagonists like elagolix and relugolix) shrink fibroids and reduce heavy bleeding, used most often before surgery to optimize surgical conditions. Levonorgestrel IUD (Mirena) effectively reduces heavy menstrual bleeding in women with fibroids not distorting the uterine cavity. Tranexamic acid and NSAIDs reduce bleeding without hormonal effects.
Minimally Invasive Treatments
Uterine fibroid embolization (UFE) blocks blood supply to fibroids, causing them to shrink — preserving the uterus with a shorter recovery than surgery. MRI-guided focused ultrasound ablates fibroid tissue non-invasively. Hysteroscopic myomectomy removes submucosal fibroids through the uterus without external incisions. Laparoscopic or robotic myomectomy removes fibroids while preserving the uterus for women who desire future pregnancy. Hysterectomy (definitive cure) is the only treatment that prevents fibroid recurrence and is the most common major surgery performed in the US.
Conclusion
Fibroids are common but not inevitably disabling. The range of available treatments — from medical management to minimally invasive procedures to surgery — means that every woman with symptomatic fibroids has options tailored to her symptoms, reproductive goals, and personal preferences. Work with your gynecologist to choose the approach that best matches your specific situation.
FAQs – Uterine Fibroids
Q1. Can fibroids turn into cancer?
A: Fibroids are benign tumors that do not transform into cancer. Uterine sarcoma (cancer) can resemble a large fibroid on imaging but is a separate, rare condition. The risk of a mass thought to be a fibroid actually being sarcoma is very low (approximately 1 in 350–500 women undergoing surgery for presumed fibroids).
Q2. Do fibroids affect pregnancy?
A: Most fibroids do not affect pregnancy. Submucosal fibroids distorting the uterine cavity and large intramural fibroids are associated with reduced implantation rates, miscarriage risk, and pregnancy complications including preterm labor and placental abruption. Symptomatic fibroids affecting fertility are treated before planned conception when appropriate.
Q3. Will fibroids grow back after treatment?
A: Myomectomy removes existing fibroids but does not prevent new ones from developing — approximately 15–30% of women who have myomectomy require repeat treatment within 5 years. UFE has lower recurrence rates but fibroids can reestablish blood supply over time. Hysterectomy is the only definitive non-recurrence treatment.
Q4. Do fibroids shrink after menopause?
A: Most fibroids shrink after menopause as estrogen levels decline. Many postmenopausal women with previously symptomatic fibroids experience significant symptom improvement or resolution. Fibroids in postmenopausal women using hormone therapy may not shrink and may continue to cause symptoms.
Q5. How are fibroids diagnosed?
A: Pelvic ultrasound is the primary diagnostic tool — both abdominal and transvaginal approaches evaluate fibroid size, number, and location. MRI provides more detailed information for surgical planning and distinguishes adenomyosis (a separate condition) from fibroids. Sonohysterography (saline infusion sonogram) better characterizes cavity-distorting submucosal fibroids.
